Brief: Lipigon And HitGen Extend Collaboration Agreement On Dyslipidemia Project
23/12/2021 07:35
Dec 23 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* LIPIGON AND HITGEN EXTEND COLLABORATION AGREEMENT ON
DYSLIPIDEMIA PROJECT
* EXTENDED COLLABORATION ON DEVELOPMENT OF SMALL MOLECULES
FOR
DYSLIPIDEMIA AND CARDIOMETABOLIC DISEASE UNTIL 7 JULY 2024
Source text for Eikon: ID:nBQN3fQnQ1
Further company coverage: 688222.SS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds